These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25305134)

  • 21. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
    Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
    J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.
    Indelicato L; Mariano V; Galasso S; Boscari F; Cipponeri E; Negri C; Frigo A; Avogaro A; Bonora E; Trombetta M; Bruttomesso D
    Diabet Med; 2017 May; 34(5):691-697. PubMed ID: 28145047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
    Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
    Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety and efficacy of programmable implantable insulin delivery systems.
    Olsen CL; Liu G; Iravani M; Nguyen S; Khourdadjian K; Turner DS; Waxman K; Selam JL; Charles MA
    Int J Artif Organs; 1993 Dec; 16(12):847-54. PubMed ID: 8175202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus.
    Spaan N; Teplova A; Stam G; Spaan J; Lucas C
    Acta Diabetol; 2014; 51(3):339-51. PubMed ID: 24595518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial.
    McTavish L; Corley B; Weatherall M; Wiltshire E; Krebs JD
    Diabet Med; 2018 Mar; 35(3):339-346. PubMed ID: 29285796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous infusion of subcutaneous compared to intravenous insulin for tight glycaemic control in medical intensive care unit patients.
    Bodur HA; Saygili F; Saygili S; Doganay LH; Yesil S
    Anaesth Intensive Care; 2008 Jul; 36(4):520-7. PubMed ID: 18714620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.
    O'Connell MA; Donath S; O'Neal DN; Colman PG; Ambler GR; Jones TW; Davis EA; Cameron FJ
    Diabetologia; 2009 Jul; 52(7):1250-7. PubMed ID: 19396424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of continuous intraperitoneal insulin infusion with an implantable pump.
    van Dijk PR; Logtenberg SJ; Groenier KH; Haveman JW; Kleefstra N; Bilo HJ
    World J Diabetes; 2012 Aug; 3(8):142-8. PubMed ID: 22912916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomized controlled trial.
    Logtenberg SJ; Kleefstra N; Houweling ST; Groenier KH; Gans RO; Bilo HJ
    Diabetes Care; 2010 Jun; 33(6):1169-72. PubMed ID: 20185731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII).
    Micossi P; Bosi E; Cristallo M; Monti LD; Librenti MC; Petrella G; Galimberti G; Spotti D; Giudici G; Vergani C
    Acta Diabetol Lat; 1986; 23(2):155-64. PubMed ID: 3751449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.